DexCom rises on Q2 beats, raised 2026 revenue guidance midpoint
Dexcom lifted its full-year forecast as quarterly revenue rose 13% and adjusted profit topped estimates, while shares gained more than 4% in extended trading.
4 Articles
4 Articles
Dexcom raises annual revenue forecast on strong demand for glucose monitors - Regional Media News
July 30 (Reuters) - Medical device maker Dexcom raised its full-year revenue forecast and beat quarterly estimates on Thursday, banking on sustained demand for its continuous glucose monitors that track blood sugar levels, sending shares of the company up over 4% in extended trading. Here are the details: • Rising awareness of diabetes care, improved insurance coverage and a wider consumer shift towards finger-prick-free technology have boosted …
Dexcom Q2 results beat expectations as sales outlook increased
A Stelo user prepares food [Image courtesy of Dexcom]Dexcom (Nasdaq:DXCM) today reported second-quarter results that came in ahead of the consensus Wall Street forecast. Shares of DXCM rose 2% to $76.02 apiece after the market closed today. The San Diego-based continuous glucose monitor (CGM) maker reported profits of $249.1 million. That equals 64¢ per share on sales of $1.31 billion for the three months ended June 30, 2026. Dexcom recorded a 3…
Coverage Details
Bias Distribution
- 67% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
